74 related articles for article (PubMed ID: 2250912)
1. Analysis by pulsed field gel electrophoresis reveals complex rearrangements in two MET alleles in a chemically-treated human cell line, MNNG-HOS.
Testa JR; Park M; Blair DG; Kalbakji A; Arden K; Vande Woude GF
Oncogene; 1990 Oct; 5(10):1565-71. PubMed ID: 2250912
[TBL] [Abstract][Full Text] [Related]
2. The human met oncogene is a member of the tyrosine kinase family.
Gonzatti-Haces M; Park M; Dean M; Blair DG; Vande Woude GF
Princess Takamatsu Symp; 1986; 17():221-32. PubMed ID: 3332011
[TBL] [Abstract][Full Text] [Related]
3. Two rearranged MET alleles in MNNG-HOS cells reveal the orientation of MET on chromosome 7 to other markers tightly linked to the cystic fibrosis locus.
Park M; Testa JR; Blair DG; Parsa NZ; Vande Woude GF
Proc Natl Acad Sci U S A; 1988 Apr; 85(8):2667-71. PubMed ID: 3282234
[TBL] [Abstract][Full Text] [Related]
4. Characterization of a c-met proto-oncogene activated in human xeroderma pigmentosum cells after treatment with N-methyl-N'-nitro-N-nitrosoguanidine (MNNG).
Michelin S; Daya-Grosjean L; Sureau F; Saïd S; Sarasin A; Suárez HG
Oncogene; 1993 Jul; 8(7):1983-91. PubMed ID: 8510940
[TBL] [Abstract][Full Text] [Related]
5. TRK-T1 is a novel oncogene formed by the fusion of TPR and TRK genes in human papillary thyroid carcinomas.
Greco A; Pierotti MA; Bongarzone I; Pagliardini S; Lanzi C; Della Porta G
Oncogene; 1992 Feb; 7(2):237-42. PubMed ID: 1532241
[TBL] [Abstract][Full Text] [Related]
6. Activation of the met oncogene in the human MNNG-HOS cell line involves a chromosomal rearrangement.
Tempest PR; Reeves BR; Spurr NK; Rance AJ; Chan AM; Brookes P
Carcinogenesis; 1986 Dec; 7(12):2051-7. PubMed ID: 3779899
[TBL] [Abstract][Full Text] [Related]
7. Lack of rearranged Tpr-met mRNA expression in human gastric cancer cell lines and gastric mucosa and carcinoma.
Osaki M; Miyata H; Hayashi A; Gomyo Y; Tatebe S; Ito H
Anticancer Res; 1996; 16(5A):2881-4. PubMed ID: 8917402
[TBL] [Abstract][Full Text] [Related]
8. Autophosphorylation modulates the kinase activity and oncogenic potential of the Met receptor tyrosine kinase.
Rodrigues GA; Park M
Oncogene; 1994 Jul; 9(7):2019-27. PubMed ID: 8208547
[TBL] [Abstract][Full Text] [Related]
9. TPR-MET oncogenic rearrangement: detection by polymerase chain reaction amplification of the transcript and expression in human tumor cell lines.
Soman NR; Wogan GN; Rhim JS
Proc Natl Acad Sci U S A; 1990 Jan; 87(2):738-42. PubMed ID: 2300559
[TBL] [Abstract][Full Text] [Related]
10. Chromosome 1 rearrangements involving the genes TPR and NTRK1 produce structurally different thyroid-specific TRK oncogenes.
Greco A; Miranda C; Pagliardini S; Fusetti L; Bongarzone I; Pierotti MA
Genes Chromosomes Cancer; 1997 Jun; 19(2):112-23. PubMed ID: 9172002
[TBL] [Abstract][Full Text] [Related]
11. Tumorigenicity assay of the human mammary carcinoma cell line MCF-7.
Marics I; Adelaide J; Rosnet O; Planche J; Pirisi V; Birnbaum D
Anticancer Res; 1989; 9(6):1627-31. PubMed ID: 2560622
[TBL] [Abstract][Full Text] [Related]
12. Molecular cloning of the breakpoint region on chromosome 6 in cutaneous malignant melanoma: evidence for deletion in the c-myb locus and translocation of a segment of chromosome 12.
Dasgupta P; Linnenbach AJ; Giaccia AJ; Stamato TD; Reddy EP
Oncogene; 1989 Oct; 4(10):1201-5. PubMed ID: 2677917
[TBL] [Abstract][Full Text] [Related]
13. Mapping of the 7q31 subregion common to the small chromosome 7 derivatives from two sporadic papillary renal cell carcinomas: increased copy number and overexpression of the MET proto-oncogene.
Glukhova L; Lavialle C; Fauvet D; Chudoba I; Danglot G; Angevin E; Bernheim A; Goguel AF
Oncogene; 2000 Feb; 19(6):754-61. PubMed ID: 10698493
[TBL] [Abstract][Full Text] [Related]
14. Identification of tyrosine 489 in the carboxy terminus of the Tpr-Met oncoprotein as a major site of autophosphorylation.
Kamikura DM; Naujokas MA; Park M
Biochemistry; 1996 Jan; 35(3):1010-7. PubMed ID: 8547236
[TBL] [Abstract][Full Text] [Related]
15. Characterization of the rearranged tpr-met oncogene breakpoint.
Dean M; Park M; Vande Woude GF
Mol Cell Biol; 1987 Feb; 7(2):921-4. PubMed ID: 3821733
[TBL] [Abstract][Full Text] [Related]
16. Identification of mutations in the coding sequence of the proto-oncogene c-kit in a human mast cell leukemia cell line causing ligand-independent activation of c-kit product.
Furitsu T; Tsujimura T; Tono T; Ikeda H; Kitayama H; Koshimizu U; Sugahara H; Butterfield JH; Ashman LK; Kanayama Y
J Clin Invest; 1993 Oct; 92(4):1736-44. PubMed ID: 7691885
[TBL] [Abstract][Full Text] [Related]
17. Mechanism of met oncogene activation.
Park M; Dean M; Cooper CS; Schmidt M; O'Brien SJ; Blair DG; Vande Woude GF
Cell; 1986 Jun; 45(6):895-904. PubMed ID: 2423252
[TBL] [Abstract][Full Text] [Related]
18. BCL3 rearrangements and t(14;19) in chronic lymphocytic leukemia and other B-cell malignancies: a molecular and cytogenetic study.
McKeithan TW; Takimoto GS; Ohno H; Bjorling VS; Morgan R; Hecht BK; Dubé I; Sandberg AA; Rowley JD
Genes Chromosomes Cancer; 1997 Sep; 20(1):64-72. PubMed ID: 9290956
[TBL] [Abstract][Full Text] [Related]
19. BCL2 complex rearrangement in follicular lymphoma: translocation mbr/JH and deletion in the vcr region of the same BCL2 allele.
Séité P; Hillion J; d'Agay MF; Berger R; Larsen CJ
Oncogene; 1993 Nov; 8(11):3073-80. PubMed ID: 8414508
[TBL] [Abstract][Full Text] [Related]
20. The t(2;3)(q21;q27) translocation in non-Hodgkin's lymphoma displays BCL6 mutations in the 5' regulatory region and chromosomal breakpoints distant from the gene.
Chen W; Butler M; Rao PH; Chaganti SR; Louie DC; Dalla-Favera R; Chaganti RS
Oncogene; 1998 Oct; 17(13):1717-22. PubMed ID: 9796700
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
